AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / PHARMACEUTICAL PREPARATIONS
ZOETIS INC.
XNYS · usd
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG0039320P7
81.03▼ 0.97 (-1.18%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close
82.00
Day's Range
80.60 – 81.86
52-Week Range
68.77 – 147.93
Volume
2.5M
Avg Volume
4.1M
Share Statistics
Shares Outstanding
Employees
14.5K
Exchange
XNYS
Listed
2013-02-01
Share count as of July 31, 2026

ZOETIS INC. (ZTS) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about ZOETIS INC. (ZTS)
What is ZOETIS INC.'s Market Cap?
ZOETIS INC.'s Market Cap is $33.5B, based on as-reported figures from SEC (XBRL) filings.
What is ZOETIS INC.'s Enterprise Value?
ZOETIS INC.'s Enterprise Value is $40.9B, based on as-reported figures from SEC (XBRL) filings.
What is ZOETIS INC.'s Trailing P/E?
ZOETIS INC.'s Trailing P/E is 12.7×, based on as-reported figures from SEC (XBRL) filings.
What is ZOETIS INC.'s Price / Sales?
ZOETIS INC.'s Price / Sales is 3.5×, based on as-reported figures from SEC (XBRL) filings.
What is ZOETIS INC.'s EV / Revenue?
ZOETIS INC.'s EV / Revenue is 4.3×, based on as-reported figures from SEC (XBRL) filings.
What is ZOETIS INC.'s EV / EBITDA?
ZOETIS INC.'s EV / EBITDA is 10.2×, based on as-reported figures from SEC (XBRL) filings.
What is ZOETIS INC.'s Revenue (TTM)?
ZOETIS INC.'s Revenue (TTM) is $9.5B, based on as-reported figures from SEC (XBRL) filings.
What is ZOETIS INC.'s Net Income (TTM)?
ZOETIS INC.'s Net Income (TTM) is $2.6B, based on as-reported figures from SEC (XBRL) filings.
What is ZOETIS INC.'s EBITDA?
ZOETIS INC.'s EBITDA is $4.0B, based on as-reported figures from SEC (XBRL) filings.
What is ZOETIS INC.'s Diluted EPS (TTM)?
ZOETIS INC.'s Diluted EPS (TTM) is 6.38, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · ZTSAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in millions of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Revenue
YoY growth-0.2%+2.9%+3.0%+0.5%
Costs and expenses:
Cost of sales
Selling, general and administrative expenses
Research and development expenses
Amortization of intangible assets
Restructuring charges and certain acquisition and divestiture-related costs
Interest expense, net of capitalized interest
Other (income)/deductions—net
Income before provision for taxes on income
Provision for taxes on income
Net income before allocation to noncontrolling interests
% of revenue28.0%26.6%25.3%30.0%
Less: Net income/(loss) attributable to noncontrolling interests
Net income attributable to Zoetis Inc.
% of revenue28.0%26.6%25.3%30.0%
Earnings per share attributable to Zoetis Inc. stockholders:
Basic (in dollars per share)
Diluted (in dollars per share)